|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pulmonary Hypertension | |||||
| Cancer | |||||
| Lung Disease | |||||
| Cardiothoracic Surgery | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hypertension | |||||
| Hypertension, Pulmonary | |||||
| Lung Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Respiratory Tract Diseases | |||||
| Vascular Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Nesiritide (Natrecor) | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Natriuretic Peptide, Brain | |||||
| 6 | More general drug interventions related to this trial | ||||
| Cardiovascular Agents | |||||
| Natriuretic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| M.D. Anderson Cancer Center | |||||